Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer | Synapse

April 25, 2023Open Access

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

RAD51 foci are a robust marker of platinum chemotherapy response and survival in ovarian cancer. The utility of RAD51 foci as a predictive biomarker for HGSOC should be tested in clinical trials.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Compadre et al. (Tue,) studied this question.

synapsesocial.com/papers/69dbda929e6f14d6f16846ed https://doi.org/https://doi.org/10.1158/1078-0432.ccr-22-3335

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo